Pharm Tech Agenda 2022.03.04: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Thagg (talk | contribs)
8 edits
Created page with "= Agenda = * Update on Sponsors ** Current events ** Strategy on stakeholder engagement * Update on work items ** Medication Management ** Supply ***Whitepaper https://driv..."
 
No edit summary
 
(One intermediate revision by one other user not shown)
Line 8: Line 8:
** Medication Management
** Medication Management
** Supply
** Supply
***Whitepaper https://drive.google.com/drive/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr
***Whitepaper  
 
Action asked --> review and suggest optimization
Action asked --> review and suggest optimization
***Supply repository https://github.com/IHE/pharm-supply
***Supply repository https://github.com/IHE/pharm-supply
***Supply result (wip)http://build.fhir.org/ig/IHE/pharm-supply/index.html
***Supply result (wip)http://build.fhir.org/ig/IHE/pharm-supply/index.html
***Catalog repository https://github.com/IHE/pharm-catalog/tree/master
***Catalog repository https://github.com/IHE/pharm-catalog/tree/master


** Vaccination
** Vaccination
Line 43: Line 41:


* Review and Approve Agenda
* Review and Approve Agenda
** Agenda approved
** Agenda revised with some changes
 
== Re-intro ==
* João brings his pharmacist and technical experience to bridge the clinical and technical actors. He has several years experience in FHIR and other standards in interoperability.
 
* Quentin works as a developer and he is involved in the CDA/FHIR connector
 
* Stephane works in Switzerland HUG and he
** Stephane is working on the FHIR and CDA interoperability, and we could use some better advancements on mapping FHIR and CDA or facilitate the adoption
** João confirms that this is a challenge also for FHIR v2. We could add something in terms of specification (mapping) or methodology etc.
** Testing phase - projectathon
 
Leonidas
Interested
Some discussion on EAHP and membership
Stephane wants to align with the Swiss rep at the EAHP.
Action item: **Maybe make a short presentation for the EAHP for roadmap and interest, to raise the interest**.
 
 
Juergen explains his role in IHE Europe Board
* **Recent challenges with FHIR maturity and standards alignment**
 
 
Hernany
Interested in bringing NL effort and knowledge
Action item: Perhaps asking the EC and NCPs to be "liaisons" to IHE.
NL is advancing and there is a strong need to keep things international.
 
 
Topics
* Adverse events (allergies, contraindications)
* Medication Management
* Medication Record
 
Trudy shares her experience from Managing healthcare by looking at processes, figuring out what needs to be fixed our bypassed.
 




== Planning Schedule ==




Latest revision as of 06:52, 4 July 2022

Agenda

  • Update on Sponsors
    • Current events
    • Strategy on stakeholder engagement
  • Update on work items
    • Medication Management
    • Supply
      • Whitepaper

Action asked --> review and suggest optimization

    • Vaccination
    • Others (Adverse Event, Medication Record/Lists, Catalogs)
  • Update on collaboration with other projects and SDOs
    • OpenHIE (Vaccination)
    • HL7
    • ISO
    • UNICOM
    • National initiaties
    • HL7 Belgium



Welcome

  • Participants
    • Marc Robberecht
    • Anne van Berkel Meier
    • Quentin Ligier
    • Hernany Silva Costa Melo
    • João Almeida
    • Michael Tan
    • José Costa Teixeira


  • Review and Approve Agenda
    • Agenda revised with some changes

Re-intro

  • João brings his pharmacist and technical experience to bridge the clinical and technical actors. He has several years experience in FHIR and other standards in interoperability.
  • Quentin works as a developer and he is involved in the CDA/FHIR connector
  • Stephane works in Switzerland HUG and he
    • Stephane is working on the FHIR and CDA interoperability, and we could use some better advancements on mapping FHIR and CDA or facilitate the adoption
    • João confirms that this is a challenge also for FHIR v2. We could add something in terms of specification (mapping) or methodology etc.
    • Testing phase - projectathon

Leonidas Interested Some discussion on EAHP and membership Stephane wants to align with the Swiss rep at the EAHP. Action item: **Maybe make a short presentation for the EAHP for roadmap and interest, to raise the interest**.


Juergen explains his role in IHE Europe Board

  • **Recent challenges with FHIR maturity and standards alignment**


Hernany Interested in bringing NL effort and knowledge Action item: Perhaps asking the EC and NCPs to be "liaisons" to IHE. NL is advancing and there is a strong need to keep things international.


Topics

  • Adverse events (allergies, contraindications)
  • Medication Management
  • Medication Record

Trudy shares her experience from Managing healthcare by looking at processes, figuring out what needs to be fixed our bypassed.



Work items

  • Supply (Project lead: Jose)
    • Current Status:
  • MM FHIR profiles
    • Current Status:
  • Vaccination (Project lead Juergen)
    • Current Status:
  • Medication record (Project lead Jose)
    • Current Status:


Any other business

Retrieved from "http://wiki.ihe.net/index.php?title=Pharm_Tech_Agenda_2022.03.04&oldid=128480"